scPharmaceuticals Inc.

Rachunek Zysków i Strat





index 0 1 2 3 4 5 6 7 8 9
Rok finansowy 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 0 0 0 0 0 0 14 36
Przychód Δ r/r 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% inf% 167.3%
Marża brutto 0.0% 0.0% 0.0% 0.0% -inf% -inf% -inf% -inf% 72.0% 68.7%
EBIT (mln) -11 -18 -23 -30 -33 -30 -26 -36 -55 -65
EBIT Δ r/r 0.0% 65.2% 30.9% 26.6% 10.9% -9.0% -13.7% 40.0% 53.2% 16.9%
EBIT (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -407.5% -178.3%
Koszty finansowe (mln) -0 7 1 1 2 3 3 3 8 8
EBITDA (mln) -11 -18 -23 -28 -31 -30 -25 -34 -55 -78
EBITDA(%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -402.9% -213.5%
Podatek (mln) -0 6 0 -0 1 2 2 1 0 0
Zysk Netto (mln) -11 -24 -24 -29 -34 -34 -30 -38 -55 -85
Zysk netto Δ r/r 0.0% 131.8% -2.3% 23.6% 16.9% -0.1% -11.4% 23.1% 46.1% 55.4%
Zysk netto (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -403.2% -234.4%
EPS -0.94 -2.18 -8.04 -1.59 -1.85 -1.4 -1.11 -1.32 -1.42 -1.91
EPS (rozwodnione) -0.94 -2.18 -8.04 -1.59 -1.85 -1.4 -1.11 -1.32 -1.42 -1.91
Ilośc akcji (mln) 11 11 3 19 19 25 27 28 39 45
Ważona ilośc akcji (mln) 11 11 3 19 19 25 27 28 39 45
Waluta USD USD USD USD USD USD USD USD USD USD